HUP0105248A3 - Prostaglandin endoperoxide h synthase biosynthesis inhibitors pyridazinone-derivatives, pharmaceutical compositions containing them as active inaredient and process for preparation the compounds - Google Patents

Prostaglandin endoperoxide h synthase biosynthesis inhibitors pyridazinone-derivatives, pharmaceutical compositions containing them as active inaredient and process for preparation the compounds

Info

Publication number: HUP0105248A3
Authority: HU; Hungary
Prior art keywords: pyridazinone; derivatives; compounds; preparation; pharmaceutical compositions
Prior art date: 1998-10-27

Application number

HU0105248A

Other languages

English (en)

Hungarian (hu)

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-27

Filing date

1999-10-27

Publication date

2002-09-30

1999-10-27 Application filed by Abbott Lab filed Critical Abbott Lab

1999-10-27 Priority claimed from US09/427,768 external-priority patent/US6307047B1/en

2002-07-29 Publication of HUP0105248A2 publication Critical patent/HUP0105248A2/hu

2002-09-30 Publication of HUP0105248A3 publication Critical patent/HUP0105248A3/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines Containing Plant Substances (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

HU0105248A 1998-10-27 1999-10-27 Prostaglandin endoperoxide h synthase biosynthesis inhibitors pyridazinone-derivatives, pharmaceutical compositions containing them as active inaredient and process for preparation the compounds HUP0105248A3 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US17960598A	1998-10-27	1998-10-27
US26187299A	1999-03-03	1999-03-03
US29849099A	1999-04-23	1999-04-23
US09/427,768 US6307047B1 (en)	1997-08-22	1999-10-27	Prostaglandin endoperoxide H synthase biosynthesis inhibitors

Publications (2)

Publication Number	Publication Date
HUP0105248A2 HUP0105248A2 (hu)	2002-07-29
HUP0105248A3 true HUP0105248A3 (en)	2002-09-30

Family

ID=27497355

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU0105248A HUP0105248A3 (en)	1998-10-27	1999-10-27	Prostaglandin endoperoxide h synthase biosynthesis inhibitors pyridazinone-derivatives, pharmaceutical compositions containing them as active inaredient and process for preparation the compounds

Country Status (19)

Country	Link
EP (1)	EP1124804B1 (de)
JP (1)	JP2003512292A (de)
KR (1)	KR100666838B1 (de)
CN (1)	CN1279026C (de)
AT (1)	ATE302759T1 (de)
BG (1)	BG65261B1 (de)
BR (1)	BR9914858A (de)
CA (1)	CA2347982A1 (de)
CZ (1)	CZ300570B6 (de)
DE (1)	DE69926903T2 (de)
DK (1)	DK1124804T3 (de)
ES (1)	ES2249919T3 (de)
HK (1)	HK1041876B (de)
HU (1)	HUP0105248A3 (de)
NO (1)	NO318623B1 (de)
PL (1)	PL198503B1 (de)
SK (1)	SK286806B6 (de)
TR (1)	TR200101765T2 (de)
WO (1)	WO2000024719A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1043317B1 (de)	1997-11-19	2009-04-15	Kowa Co., Ltd.	Pyridazinderivate und diese als aktiven bestandteil enthaltende medikamente
TWI241295B (en)	1998-03-02	2005-10-11	Kowa Co	Pyridazine derivative and medicine containing the same as effect component
JP2000247959A (ja)	1999-02-26	2000-09-12	Kowa Co	ピリダジン−３−オン誘導体及びこれを含有する医薬
SK12672001A3 (sk)	1999-12-08	2002-04-04	Pharmacia Corporation	Zloženia inhibítora cyklooxygenázy-2 s rýchlym nástupom terapeutického účinku
US6664256B1 (en)	2000-07-10	2003-12-16	Kowa Co., Ltd.	Phenylpyridazine compounds and medicines containing the same
US6716829B2 (en)	2000-07-27	2004-04-06	Pharmacia Corporation	Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
AR030741A1 (es)	2000-09-15	2003-09-03	Pharmacia Corp	Derivados de los acidos 2-amino-2-alquil-5-heptenoico y - heptinoico utiles como inhibidores de oxido nitrico sintetasa
AR031129A1 (es)	2000-09-15	2003-09-10	Pharmacia Corp	Derivados de los acidos 2-amino-2-alquil-4-hexenoico y -hexinoico utiles como inhibidores de oxido nitrico sintetasa
US7012098B2 (en)	2001-03-23	2006-03-14	Pharmacia Corporation	Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
DE10129320A1 (de)	2001-06-19	2003-04-10	Norbert Mueller	Verwendung von COX-2 Inhibitoren zur Behandlung von Schizophrenie, wahnhaften Störungen, affektiven Störungen oder Ticstörungen
NZ534395A (en)	2002-02-14	2006-10-27	Pharmacia Corp	Substituted pyridinones as modulators of p38 MAP kinase
SI1572173T1 (sl)	2002-12-13	2010-08-31	Warner Lambert Co	Alfa-2-delta ligand za zdravljenje simptomov spodnjega dela sečil
US20040204411A1 (en) *	2002-12-17	2004-10-14	Pharmacia Corporation	Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
ES2211344B1 (es) *	2002-12-26	2005-10-01	Almirall Prodesfarma, S.A.	Nuevos derivados de piridazin-3(2h)-ona.
EP1604984A1 (de)	2003-03-18	2005-12-14	Kowa Co., Ltd.	Wasserlösliches phenylpyridazinderivat und medikament, das dieses enthält
EP1745791B1 (de)	2003-05-07	2013-06-26	Osteologix A/S	Behandlung von Knorpel/Knochen-Erkrankungen mit wasserlöslichen Strontiumsalzen
ES2251866B1 (es)	2004-06-18	2007-06-16	Laboratorios Almirall S.A.	Nuevos derivados de piridazin-3(2h)-ona.
US7728031B2 (en)	2006-02-24	2010-06-01	Abbott Laboratories	Octahydro-pyrrolo[3,4-b]pyrrole derivatives
EP1916240A1 (de) *	2006-10-25	2008-04-30	Syngeta Participations AG	Neue Pyridazin-Derivate
EA017171B1 (ru)	2006-12-22	2012-10-30	Рекордати Айерленд Лимитед	КОМБИНИРОВАННАЯ ТЕРАПИЯ ЗАБОЛЕВАНИЙ НИЖНИХ МОЧЕВЫВОДЯЩИХ ПУТЕЙ С ИСПОЛЬЗОВАНИЕМ ЛИГАНДОВ αδ И НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ПРЕПАРАТОВ (НПВП)
DE102007008839A1 (de) *	2007-02-23	2008-08-28	Bayer Healthcare Ag	Verfahren zur Herstellung von 4-(3-Hydroxy-3-methyl-butoxy)-5-[4-(methylsulfonyl)phenyl]-2-arylpyridazin-3(2H)-onen
DE102007008840A1 (de)	2007-02-23	2008-08-28	Bayer Healthcare Ag	Neue polymorphe Form von 2-(4-Fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy)-5-[4-methylsulfonyl)phenyl]-3(2H)-pyridazinon (FHMP)
DE102007008843A1 (de)	2007-02-23	2008-08-28	Bayer Healthcare Ag	Verfahren zur Herstellung von 4,5-Dihalogen-2-aryl-2H-pyridazin-3-onen
DE102007020690A1 (de)	2007-05-03	2008-11-06	Bayer Healthcare Ag	Neue amorphe Form von 2-(4-Fluorophenyl)-4-3-hydroxy-3-mehtyl-1-butoxy)-6[4-methylsulfonyl)phenyl]-3(2H)-pyridazinon (FHMP)
DE102007020689A1 (de)	2007-05-03	2008-11-06	Bayer Healthcare Ag	Neue polymorphe Form von 2-(4-Fluorophenyl)-4-3-hydroxy-3-methyl-1-butoxy-5-[4-methylsulfonyl)phenyl]3/2H)-pyridazinon (FHMP)
DE102007025717A1 (de) *	2007-06-01	2008-12-11	Merck Patent Gmbh	Arylether-pyridazinonderivate
GB0716414D0 (en) *	2007-08-22	2007-10-03	Syngenta Participations Ag	Novel insecticides
EP2188288A1 (de)	2007-09-11	2010-05-26	Abbott Laboratories	Octahydropyrrolo[3,4-b]pyrrol-n-oxide
GB0903493D0 (en)	2009-02-27	2009-04-08	Vantia Ltd	New compounds
JP2012131708A (ja) *	2009-04-28	2012-07-12	Nissan Chem Ind Ltd	４位置換ピリダジノン化合物及びｐ２ｘ７受容体阻害剤
FR2969606B1 (fr) *	2010-12-22	2013-01-11	Pf Medicament	Derives de diarylpyridazinones, leur preparation et leur application en therapeutique humaine
JO3115B1 (ar)	2011-08-22	2017-09-20	Takeda Pharmaceuticals Co	مركبات بيريدازينون واستخدامها كمثبطات daao
US11583516B2 (en)	2016-09-07	2023-02-21	Trustees Of Tufts College	Dash inhibitors, and uses related thereto
CN107334767B (zh) *	2017-06-08	2019-03-05	中国医学科学院医药生物技术研究所	一种哒嗪酮类化合物在肿瘤治疗中的应用
WO2021124344A1 (en) *	2019-12-18	2021-06-24	Abida	Pyridazine derivatives and their use as cyclooxygenase-2 inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4238490A (en) *	1979-02-12	1980-12-09	Diamond Shamrock Corporation	Antihypertensive pyridazin(2H)-3-ones
JPS57501328A (de) *	1980-08-07	1982-07-29
US5622948A (en) *	1994-12-01	1997-04-22	Syntex (U.S.A.) Inc.	Pyrrole pyridazine and pyridazinone anti-inflammatory agents
CA2224563A1 (en) *	1995-06-12	1996-12-27	G.D. Searle & Co.	Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
JP2001514669A (ja) *	1997-03-14	2001-09-11	メルクフロストカナダアンドカンパニー	シクロオキシゲナーゼ−２阻害薬としてのピリダジノン類
DE69833774T2 (de) *	1997-08-22	2007-04-26	Abbott Laboratories, Abbott Park	Prostaglandin endoperoxyde h synthase biosynthese inhibitoren
CA2299300C (en) *	1997-08-22	2007-04-17	Abbott Laboratories	Arylpyridazinones as prostaglandin endoperoxide h synthase bisoynthesis inhibitors
IL133552A (en) *	1997-08-22	2005-12-18	Abbott Lab	Arylpyridazinones as prostaglandin endoperoxide h synthase biosynthesis inhibitors

1999
- 1999-10-27 PL PL349256A patent/PL198503B1/pl not_active IP Right Cessation
- 1999-10-27 WO PCT/US1999/025234 patent/WO2000024719A1/en active Application Filing
- 1999-10-27 CA CA002347982A patent/CA2347982A1/en not_active Abandoned
- 1999-10-27 CZ CZ20011481A patent/CZ300570B6/cs not_active IP Right Cessation
- 1999-10-27 ES ES99953259T patent/ES2249919T3/es not_active Expired - Lifetime
- 1999-10-27 TR TR2001/01765T patent/TR200101765T2/xx unknown
- 1999-10-27 SK SK554-2001A patent/SK286806B6/sk not_active IP Right Cessation
- 1999-10-27 EP EP99953259A patent/EP1124804B1/de not_active Expired - Lifetime
- 1999-10-27 BR BR9914858-7A patent/BR9914858A/pt not_active IP Right Cessation
- 1999-10-27 CN CNB998147265A patent/CN1279026C/zh not_active Expired - Fee Related
- 1999-10-27 DK DK99953259T patent/DK1124804T3/da active
- 1999-10-27 JP JP2000578289A patent/JP2003512292A/ja not_active Ceased
- 1999-10-27 KR KR1020017005342A patent/KR100666838B1/ko not_active IP Right Cessation
- 1999-10-27 AT AT99953259T patent/ATE302759T1/de not_active IP Right Cessation
- 1999-10-27 DE DE69926903T patent/DE69926903T2/de not_active Expired - Lifetime
- 1999-10-27 HU HU0105248A patent/HUP0105248A3/hu unknown
2001
- 2001-04-26 NO NO20012061A patent/NO318623B1/no not_active IP Right Cessation
- 2001-05-19 BG BG105523A patent/BG65261B1/bg unknown
2002
- 2002-02-19 HK HK02101207.5A patent/HK1041876B/zh not_active IP Right Cessation

Also Published As

Publication number	Publication date
HK1041876B (zh)	2006-06-23
CA2347982A1 (en)	2000-05-04
NO318623B1 (no)	2005-04-18
JP2003512292A (ja)	2003-04-02
TR200101765T2 (tr)	2002-02-21
SK5542001A3 (en)	2001-12-03
EP1124804B1 (de)	2005-08-24
HUP0105248A2 (hu)	2002-07-29
NO20012061D0 (no)	2001-04-26
PL198503B1 (pl)	2008-06-30
KR100666838B1 (ko)	2007-01-11
CN1342149A (zh)	2002-03-27
ES2249919T3 (es)	2006-04-01
BG105523A (en)	2001-12-29
EP1124804A1 (de)	2001-08-22
DE69926903T2 (de)	2006-07-13
CZ20011481A3 (cs)	2001-09-12
ATE302759T1 (de)	2005-09-15
BG65261B1 (bg)	2007-10-31
BR9914858A (pt)	2002-02-05
CN1279026C (zh)	2006-10-11
DK1124804T3 (da)	2005-12-12
HK1041876A1 (en)	2002-07-26
WO2000024719A1 (en)	2000-05-04
DE69926903D1 (en)	2005-09-29
CZ300570B6 (cs)	2009-06-17
SK286806B6 (sk)	2009-05-07
KR20010081101A (ko)	2001-08-27
PL349256A1 (en)	2002-07-01
NO20012061L (no)	2001-06-27

Publication	Publication Date	Title
HUP0105248A3 (en)	2002-09-30	Prostaglandin endoperoxide h synthase biosynthesis inhibitors pyridazinone-derivatives, pharmaceutical compositions containing them as active inaredient and process for preparation the compounds
AU2001289751A1 (en)	2002-02-13	Selective pde 2 inhibitors, used as medicaments for improving cognition
AU8765401A (en)	2002-02-18	Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation andpharmaceutical compositions comprising them
HUP0000748A2 (en)	2001-03-28	4-phenyl-piridine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0103633A2 (hu)	2002-02-28	Szubsztituált 3-cianokinolinok mint protein tirozin kinázok inhibitorai, eljárás a vegyületek előállítására és a vegyületeket tartalmazó gyógyászati készítmények
HUP0102472A3 (en)	2002-12-28	Amidino compounds usable as nitric oxide synthase inhibitors, and process for their preparation and pharmaceutical compositions containing them
HUP0102334A3 (en)	2003-12-29	Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing the compound
WO2001029055A3 (fr)	2002-02-14	Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
HK1072729A1 (en)	2005-09-09	Gamma-aminobutyric acid derivatives containing, solid compositions and process for preparing the same
AU2002358676A1 (en)	2003-06-30	Hydroxyphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
HUP0203422A3 (en)	2004-12-28	Imidazole derivatives as phosphodiesterase vii inhibitors, process for their preparation and pharmaceutical compositions containing them
HU0100489D0 (en)	2001-04-28	New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0105479A3 (en)	2002-06-28	Betha-alanine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0202988A3 (en)	2004-12-28	Substituted 3-phenyl-5-alkoxi-1,3,4-oxdiazol-2-one derivatives and their use as lipase inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0204001A3 (en)	2005-04-28	Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0303361A3 (en)	2007-03-28	Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them
AU2002210632A1 (en)	2002-04-22	Novel aminotriazolone compounds, method for preparing same and pharmaceutical compositions containing same
HUP0202379A3 (en)	2003-04-28	New compounds, process for producing them and pharmaceutical compositions containing them
AU2001256568A1 (en)	2001-11-20	New compounds having anticancer activity: process for their preparation and pharmaceutical compositions containing them
HUP0201916A3 (en)	2003-05-28	Ethanesulfonyl-piperidine derivatives, process for producing them and pharmaceutical compositions containing them
HUP0204430A3 (en)	2005-05-30	Method for the enzymatic resolution of the racemates of aminomethyl-aryl-cyclohexanol derivatives, the obtained new compounds and pharmaceutical compositions containing thereof
HUP0204135A3 (en)	2005-03-29	Arnesyl transferase inhibitors, process for their preparation and pharmaceutical compositions containing them
AU5525199A (en)	2000-03-21	N-hydroxyacylamino compounds, process for their preparation and pharmaceutical compositions containing them
HUP0003991A2 (en)	2002-06-29	Serotonin-reuptake inhibitor ciano-indole derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0004543A3 (en)	2001-11-28	Aminopyrroline compounds, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date	Code	Title	Description
2011-07-28	FD9A	Lapse of provisional protection due to non-payment of fees